CN1095284A - The pharmaceutical formulation and the processing method of treatment gastroduodenal ulcer - Google Patents
The pharmaceutical formulation and the processing method of treatment gastroduodenal ulcer Download PDFInfo
- Publication number
- CN1095284A CN1095284A CN 93106068 CN93106068A CN1095284A CN 1095284 A CN1095284 A CN 1095284A CN 93106068 CN93106068 CN 93106068 CN 93106068 A CN93106068 A CN 93106068A CN 1095284 A CN1095284 A CN 1095284A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- rhizoma
- myrrha
- olibanum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A kind of pharmaceutical formulation and processing method for the treatment of gastroduodenal ulcer got 0.05～0.3 part of Rhizoma Corydalis, 0.02～0.2 part of Myrrha, 0.02～0.2 part of Olibanum, 0.02～0.2 part of Fructus Toosendan, 0.02～0.2 part of Radix Aucklandiae (Radix Vladimiriae), 0.02～0.2 part of Radix Curcumae, 0.02～0.2 part of Os Sepiae, 0.005～0.08 part of Fructus Evodiae, 0.01～0.15 part of Rhizoma Cyperi, 0.01～0.15 part of Fructus Amomi, 0.008～0.1 part of Rhizoma Coptidis, 0.008～0.12 part of the Radix Linderae.Above-mentioned each medicated powder is broken, soak the after-filtration taking liquid with 95% ethanol, be condensed into the extractum shape, make granule shape electuary with powdered sugar, dextrin etc. and take.
Description
The present invention relates to a kind of prescription and processing method for the treatment of the Chinese patent medicine of gastroduodenal ulcer disease.
Gastroduodenal ulcer is a kind of commonly encountered diseases, and its pathogenic factor is often relevant with factors such as patient's spiritual effects on neural system, diet effect, other causes of disease.Belong to the patient that feelings will is hindered, how angry by being worried, for a long time strongly fragrant not understanding causes depression of liver-QI, and perverse and unreasonable manner is violated stomach, and protracted course of disease can transform and cause primary disease.The patient who belongs to injury due to diet, how full undesired because of famine, eating and drinking too much at one meal, impairing the spleen and stomach and produce gastric abscess.Belong to the patient that other pathological changes causes, have because of the gastric mucosa resistance reduces and the gastric acid secretion increasing causes a disease, just like diet, medicine reason, gastric mucosa iron deficiency, anoxia, pylorus dysfunction, and bile stimulation, certain endocrine disturbance's grade causes and causes a disease.The cardinal symptom of gastroduodenal ulcer is: pain, acid regurgitation, feel sick, vomiting, upper abdomen feeling of distension and oppression, fidgety insomnia, hyperhidrosis etc., it is hemorrhage that weight person understands, as haematemesis, have blood in stool.Therefore, the medicine of treatment gastroduodenal ulcer is to choose reducing swelling and alleviating pain, removing the necrotic tissue and promoting granulation, and blood circulation promoting and blood stasis dispelling, dispersing the depressed liver-QI for alleviating pain, the gastric acid inhibitory supersecretion helps to melt the short function such as more of stomach and convergence.And the major defect of the prescription of the Chinese patent medicine of existing treatment gastroduodenal ulcer is to act on not comprehensively, controls some symptom partially, has influenced action effect.
The purpose of this invention is to provide a kind of wide adaptability, cold-damp and usefulness, the prescription and the processing method of the Chinese patent medicine of the treatment gastroduodenal ulcer that collect soothing the liver, circulation of qi promoting, invigorate blood circulation, analgesia, removing dampness, antacid, effect such as be amusing is dissolved in one.
The pharmaceutical formulation that the present invention treats gastroduodenal ulcer is: be made up of institutes such as Rhizoma Corydalis, Myrrha, Olibanum, Fructus Toosendan, Radix Aucklandiae (Radix Vladimiriae), Radix Curcumae and Os Sepiae, it gets 0.15～0.5 part of Rhizoma Corydalis by weight, 0.08～0.3 part of Myrrha, 0.08～0.3 part of Olibanum, 0.07～0.3 part of Fructus Toosendan, 0.07～0.3 part of Radix Aucklandiae (Radix Vladimiriae), 0.07～0.3 part of Radix Curcumae, 0.07～0.3 part of Os Sepiae.
The present invention treats the pharmaceutical formulation of gastroduodenal ulcer, by Rhizoma Corydalis, Myrrha, Olibanum, Fructus Toosendan, Radix Aucklandiae (Radix Vladimiriae), Radix Curcumae, Os Sepiae, Fructus Evodiae, Rhizoma Cyperi, Fructus Amomi, Rhizoma Coptidis, the Radixs Linderae etc. are formed, it gets 0.05～0.3 part of Rhizoma Corydalis by weight, 0.02～0.2 part of Myrrha, 0.02～0.2 part of Olibanum, 0.02～0.2 part of Fructus Toosendan, 0.02～0.2 part of Radix Aucklandiae (Radix Vladimiriae), 0.02～0.2 part of Radix Curcumae, 0.02～0.2 part of Os Sepiae, 0.005～0.08 part of Fructus Evodiae, 0.01～0.15 part of Rhizoma Cyperi, 0.01～0.15 part of Fructus Amomi, 0.008～0.1 part of Rhizoma Coptidis, 0.008～0.12 part of the Radix Linderae.
The pharmaceutical formulation of treatment gastroduodenal ulcer of the present invention, its composition active ingredient is: get 0.15～0.2 part of Rhizoma Corydalis, 0.08～0.15 part of Myrrha, 0.08～0.15 part of Olibanum, 0.07～0.1 part of Fructus Toosendan, 0.07～0.1 part of Radix Aucklandiae (Radix Vladimiriae), 0.07～0.1 part of Radix Curcumae, 0.07～0.1 part of Os Sepiae, 0.002～0.06 part of Fructus Evodiae, 0.05～0.08 part of Rhizoma Cyperi, 0.05～0.08 part of Fructus Amomi, 0.03～0.06 part of Rhizoma Coptidis, 0.04～0.07 part of the Radix Linderae.
The processing method of the Chinese patent medicine of treatment gastroduodenal ulcer of the present invention is got 0.05～0.3 part of Rhizoma Corydalis, 0.02～0.2 part of Myrrha, 0.02～0.2 part of Olibanum, 0.02～0.2 part of Fructus Toosendan, 0.02～0.2 part of Radix Aucklandiae (Radix Vladimiriae), 0.02～0.2 part of Radix Curcumae, 0.02～0.2 part of Os Sepiae, 0.005～0.08 part of Fructus Evodiae, 0.01～0.15 part of Rhizoma Cyperi, 0.01～0.15 part of Fructus Amomi, 0.008～0.1 part of Rhizoma Coptidis, 0.008～0.12 part of the Radix Linderae, above-mentioned each medicated powder is broken, cross 16 mesh sieves, in the ethanol with powder immersion 95%, spend 20～30 hours, take out wet-milling percolator (95% ethanol percolation of packing into, 10 milliliters of about per minutes), take out percolate, heating is condensed into extractum, medicinal residues added decocting after other got percolation, with medicinal residues: water=1: 5, fry in shallow oil the after-filtration taking liquid, heating is condensed into extractum, merge two extractum, get 0.02～0.1 part of extractum again, 0.1～0.9 part of powdered sugar, 0.05～0.4 part in dextrin, mix homogeneously is made granule shape electuary.
The present invention treats the medicine of gastroduodenal ulcer, with the initiation reason and the symptom of its disease, adopts Fructus Evodiae, Radix Aucklandiae (Radix Vladimiriae), the Radix Linderae, Rhizoma Cyperi, Fructus Amomi, Radix Curcumae and Rhizoma Corydalis, Fructus Toosendan, promoting the circulation of QI to relieve pain; With Rhizoma Corydalis, Olibanum, the pain relieving of Myrrha regulating qi and activating blood; With Fructus Evodiae, its gastric acid of Rhizoma Coptidis system; With the Os Sepiae astringing to arrest bleeding; Hold back mouth with Os Sepiae, Olibanum, Myrrha granulation promoting, close the side of forming, can be regulating QI, invigorate blood circulation, antacid, the function of stopping blooding, holding back mouthful, have multiple usefulness such as depressed liver-energy dispersing and QI regulating, resolving depression eliminating stagnation, promoting the circulation of QI to relieve pain, removing the necrotic tissue and promoting granulation, detoxifcation, convergence antacid, the appetizing of being amusing.The Chinese patent medicine granule that above medicine is made through clinical practice, has significant curative effect to gastritis, gastroduodenal ulcer.
Claims (4)
1, the pharmaceutical formulation of treatment gastroduodenal ulcer, formed by Rhizoma Corydalis, Myrrha, Olibanum, Fructus Toosendan, Radix Aucklandiae (Radix Vladimiriae), Radix Curcumae and Os Sepiae, it is characterized in that getting 0.15～0.5 part of Rhizoma Corydalis, 0.08～0.3 part of Myrrha, 0.08～0.3 part of Olibanum, 0.07～0.3 part of Fructus Toosendan, 0.07～0.3 part of Radix Aucklandiae (Radix Vladimiriae), 0.07～0.3 part of Radix Curcumae, 0.07～0.3 part of Os Sepiae.
2, the pharmaceutical formulation of treatment gastroduodenal ulcer, by Rhizoma Corydalis, Myrrha, Olibanum, Fructus Toosendan, Radix Aucklandiae (Radix Vladimiriae), Radix Curcumae, Os Sepiae, Fructus Evodiae, Rhizoma Cyperi, Fructus Amomi, Rhizoma Coptidis, the Radix Linderae is formed, it is characterized in that getting 0.05～0.3 part of Rhizoma Corydalis, 0.02～0.2 part of Myrrha, 0.02～0.2 part of Olibanum, 0.02～0.2 part of Fructus Toosendan, 0.02～0.2 part of Radix Aucklandiae (Radix Vladimiriae), 0.02～0.2 part of Radix Curcumae, 0.02～0.2 part of Os Sepiae, 0.005～0.08 part of Fructus Evodiae, 0.01～0.15 part of Rhizoma Cyperi, 0.01～0.15 part of Fructus Amomi, 0.008～0.1 part of Rhizoma Coptidis, 0.008～0.12 part of the Radix Linderae.
3, the pharmaceutical formulation of treatment gastroduodenal ulcer as claimed in claim 2 is characterized in that getting 0.15～0.2 part of Rhizoma Corydalis, 0.08～0.15 part of Myrrha, 0.08～0.15 part of Olibanum, 0.07～0.1 part of Fructus Toosendan, 0.07～0.1 part of Radix Aucklandiae (Radix Vladimiriae), 0.07～0.1 part of Radix Curcumae, 0.07～0.1 part of Os Sepiae, 0.02～0.06 part of Fructus Evodiae, 0.05～0.08 part of Rhizoma Cyperi, 0.05～0.08 part of Fructus Amomi, 0.03～0.06 part of Rhizoma Coptidis, 0.04～0.07 part of the Radix Linderae.
4, the processing method of the Chinese patent medicine of treatment gastroduodenal ulcer, it is characterized in that getting 0.05～0.3 part of Rhizoma Corydalis, 0.02～0.2 part of Myrrha, 0.02～0.2 part of Olibanum, 0.02～0.2 part of Fructus Toosendan, 0.02～0.2 part of Radix Aucklandiae (Radix Vladimiriae), 0.02～0.2 part of Radix Curcumae, 0.02～0.2 part of Os Sepiae, 0.005～0.08 part of Fructus Evodiae, 0.01～0.15 part of Rhizoma Cyperi, 0.01～0.05 part of Fructus Amomi, 0.008～0.1 part of Rhizoma Coptidis, 0.008～0.12 part of the Radix Linderae, above-mentioned each medicated powder is broken, cross 16 mesh sieves, in the ethanol with powder immersion 95%, spend 20～30 hours, take out the wet-milling percolator of packing into, get percolate, heating is condensed into extractum; Medicinal residues added decocting after other got percolation, fried in shallow oil the after-filtration taking liquid, and heating is condensed into extractum, merges two extractum, gets 0.02～0.1 part of extractum again, 0.1～0.9 part of powdered sugar, and 0.05～0.4 part in dextrin, mix homogeneously is made granule shape electuary.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93106068 CN1095284A (en) | 1993-05-15 | 1993-05-15 | The pharmaceutical formulation and the processing method of treatment gastroduodenal ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93106068 CN1095284A (en) | 1993-05-15 | 1993-05-15 | The pharmaceutical formulation and the processing method of treatment gastroduodenal ulcer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1095284A true CN1095284A (en) | 1994-11-23 |
Family
ID=4986056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93106068 Pending CN1095284A (en) | 1993-05-15 | 1993-05-15 | The pharmaceutical formulation and the processing method of treatment gastroduodenal ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1095284A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0981360A4 (en) * | 1997-05-06 | 2001-05-23 | Amylin Pharmaceuticals Inc | Method for preventing gastritis using amylin or amylin agonists |
| CN1069211C (en) * | 1998-08-24 | 2001-08-08 | 何宗祥 | Gastrosis plaster |
| CN100413530C (en) * | 2005-03-23 | 2008-08-27 | 刘朝辉 | Honey pill for treating stomach duct welling abscess and its preparation technology |
| CN101108229B (en) * | 2006-07-21 | 2010-05-12 | 山东轩竹医药科技有限公司 | Medicament for treating tummy bug |
| CN102727555A (en) * | 2012-07-18 | 2012-10-17 | 余良德 | Traditional Chinese medicine for treating gastritis, gastric ulcer and duodenal ulcer and preparation method |
| CN104825691A (en) * | 2015-05-30 | 2015-08-12 | 青岛辰达生物科技有限公司 | Traditional Chinese medicine composition for treating duodenal ulcer and application of traditional Chinese medicine composition |
| CN105168794A (en) * | 2015-11-03 | 2015-12-23 | 李金友 | Pharmaceutical composition and preparation method, preparations and application thereof |
| CN108310296A (en) * | 2018-04-23 | 2018-07-24 | 党东 | A kind of Solid oral pharmaceutical for treating stomach trouble |
-
1993
- 1993-05-15 CN CN 93106068 patent/CN1095284A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0981360A4 (en) * | 1997-05-06 | 2001-05-23 | Amylin Pharmaceuticals Inc | Method for preventing gastritis using amylin or amylin agonists |
| CN1069211C (en) * | 1998-08-24 | 2001-08-08 | 何宗祥 | Gastrosis plaster |
| CN100413530C (en) * | 2005-03-23 | 2008-08-27 | 刘朝辉 | Honey pill for treating stomach duct welling abscess and its preparation technology |
| CN101108229B (en) * | 2006-07-21 | 2010-05-12 | 山东轩竹医药科技有限公司 | Medicament for treating tummy bug |
| CN102727555A (en) * | 2012-07-18 | 2012-10-17 | 余良德 | Traditional Chinese medicine for treating gastritis, gastric ulcer and duodenal ulcer and preparation method |
| CN104825691A (en) * | 2015-05-30 | 2015-08-12 | 青岛辰达生物科技有限公司 | Traditional Chinese medicine composition for treating duodenal ulcer and application of traditional Chinese medicine composition |
| CN105168794A (en) * | 2015-11-03 | 2015-12-23 | 李金友 | Pharmaceutical composition and preparation method, preparations and application thereof |
| CN108310296A (en) * | 2018-04-23 | 2018-07-24 | 党东 | A kind of Solid oral pharmaceutical for treating stomach trouble |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705843A (en) | Medicine for treating stomach diseases | |
| CN101401925B (en) | Traditional Chinese medicine decoction for treating fatty liver | |
| CN102949630B (en) | Traditional Chinese medicine composition for treating abdominal distension caused by lack of gastrointestinal motility | |
| CN103495040A (en) | Traditional Chinese medicine composition for treating reflux esophagitis and preparation method of granule formulation thereof | |
| CN101041050A (en) | Chinese traditional medicine compound took orally for treating chronic gastritis | |
| CN1682878A (en) | Medicine for treating digestive tract ulcer and stomach cercinoma prophase pathologic change | |
| CN107441409A (en) | Chinese medicine composition for treating habitual constipation and preparation method thereof | |
| CN1095284A (en) | The pharmaceutical formulation and the processing method of treatment gastroduodenal ulcer | |
| CN103381266B (en) | Traditional Chinese medicine for treating nervous vomiting | |
| CN101530580B (en) | Drug for curing ulcerative colitis | |
| CN101085085A (en) | Beverage containing hyacinth bean, citrus medica and other components with antidiarrheal function | |
| CN102698136B (en) | Bunge cherry seed Chinese medicinal decoction for treating constipation and preparation method thereof | |
| CN101073648A (en) | Method for treating senile constipation | |
| CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
| CN101239162B (en) | Traditional Chinese medicine composition for treating stomach disease | |
| CN112675236A (en) | Traditional Chinese medicine formula preparation for treating chronic lumbago | |
| CN102764385B (en) | Medicine for treating venereophobia and application of medicine | |
| CN109010778A (en) | A kind of clearing damp Chinese medicine composition and preparation method thereof | |
| CN102988912A (en) | Oral liquid for treating chronic superficial gastritis, and preparation method thereof | |
| CN1233346C (en) | Novel medicine for treating urinary retention and preparing method thereof | |
| CN101181614B (en) | Medicament for curing podosoma numbness caused by cerebrovascular disease | |
| CN101961481A (en) | Traditional Chinese medicine for treating liver-gallbladder qi stagnation type cholecystitis and preparation method thereof | |
| CN1242772C (en) | Chinese medicine for hemorrhoid | |
| CN117064966A (en) | Solid beverage formula for conditioning constipation and preparation method thereof | |
| CN105079661A (en) | Traditional Chinese medicine composition for treating hemafecia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |